11:11 AM EDT, 10/14/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week tracking higher late Monday morning, rising 0.44% to 1,432.38 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications operator VEON (VEON) and software firm SAP (SAP), which rose 2.7% and 1.1%, respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and telecommunications company Nokia ( NOK ) , which were up 0.8% and 0.6%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and internet browser company Opera (OPRA), which fell 3.1% and 2.2%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and biotech firm Evaxion Biotech ( EVAX ) , which lost 1.8% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Verona Pharma ( VRNA ) , which increased 2.3% and 1.6%, respectively. They were followed by insurance company Prudential (PUK) and biopharmaceutical company Amarin ( AMRN ) , which were up 0.7%, each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which dropped 16% and 6.2%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were down 2.2% and 1.9%, respectively.